Both enhancer of zeste homolog 2 expression and H3 lysine 27 trimethylation deletion predicted a worse prognosis, but enhancer of zeste homolog 2 has no correlation with H3 lysine 27 trimethylation expression in meningiomas. Here, EZH2 is linked to meningioma.